NSEAnalysts/Institutional Investor Meet/Con. Call Updates29 Oct 2026 · 29 Oct 2026, 06:32 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Senores Pharmaceuticals Limited · SENORES
✦ AI SummaryResults
Senores Pharmaceuticals Limited has informed the Exchange about the link of the recording of their earnings conference call for Q2 & H1FY27, which was held on October 29, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Senores Pharmaceuticals Limited has informed the Exchange about Link of Recording
Attachments (1)
📄pdf
Download →
SENORES_29102026183215_Outcome_of_Investor_Call.pdf
View document text
Date: October 29, 2026
To, To,
Sr. General Manager Sr. General Manager
Listing Department Listing Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street Bandra Kurla Complex
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
BSE Scrip Code: 544319 NSE Symbol: SENORES
Sub.: Audio recording of Earnings Conference Call for Q2 & H1FY27
Dear Sir/Ma’am,
With reference to our intimation(s) dated October 22, 2026 and October 23, 2026 pertaining to intimation
regarding hosting earnings call to discuss the financial performance of the Company for Q2 & H1FY27.
Please find below the link of Audio recording of earnings call held on Thursday, October 29, 2026.
https://senorespharma.com/investor-meet/.
You are requested to take the same on record.
Thanking you.
For Senores Pharmaceuticals Limited
Shilpa Sharma
Company Secretary & Compliance Officer
Membership Number: A34516
Senores Pharmaceuticals Limited
1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park,
Ambali Bopal Road, Ahmedabad‐380054, Gujarat, India
P: +91 79 2999 9857 | E: info@senorespharma.com
W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263